Value of imaging findings in predicting post-operative recurrence of desmoid-type fibromatosis

被引:7
作者
Wang, Junyan [1 ,4 ]
Huang, Yijuan [2 ]
Sun, Yanbao [2 ]
Ge, Yuxi [3 ]
Zhang, Minming [1 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 2, Dept Radiol, 88 Jiefang Rd, Hangzhou 310009, Zhejiang, Peoples R China
[2] Jiaxing Univ, Affiliated Hosp 1, Hosp Jiaxing 1, Dept Radiol, Jiaxing 314000, Zhejiang, Peoples R China
[3] Jiangnan Univ, Affiliated Hosp, Dept Radiol, Wuxi 214062, Jiangsu, Peoples R China
[4] Zhejiang Chinese Med Univ, Jiaxing Chinese Med Hosp, Radiol Dept, Jiaxing 314000, Zhejiang, Peoples R China
关键词
desmoid-type fibromatosis; recurrence; imaging findings; sex; tumor maximum diameter; Ki-67; T2 signal ratio; AGGRESSIVE FIBROMATOSIS; SURGICAL RESECTION; SEE POLICY; TUMORS; MANAGEMENT; SERIES;
D O I
10.3892/ol.2019.11129
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Desmoid-type fibromatosis is a rare type of soft-tissue tumor originating from connective tissue of the fascia or aponeurosis, which exhibits aggressive growth, high likelihood of relapse and less frequent distant metastasis. The present study aimed to predict the recurrence rate and time by retrospectively analyzing the clinical data (sex, age and recurrence time), imaging findings [tumor location, maximum diameter, border, computed tomography (CT) enhancement ratio, magnetic resonance enhancement ratio and T2 signal ratio] and pathological features (Ki-67 and microscopic margin) in a total of 102 cases of pathologically confirmed desmoid-type fibromatosis. The risk ratio of each factor was calculated using the Cox proportional hazards regression model and the cumulative recurrence-free survival rate was determined using the Kaplan-Meier method and the log-rank test. The cohort comprised of 73 females and 29 males, with mean age of 32.86 +/- 12.64 years (range, 6-78 years). The 1-year and 2-year recurrence rate was 31 and 54%, respectively. The median age at recurrence was 29 years. Univariate analysis indicated that sex, maximum tumor diameter, CT enhancement ratio and Ki-67 had a significant effect on the recurrence time. Furthermore, multivariate analysis revealed that sex, maximum tumor diameter, Ki-67 and T2 signal ratio were independently associated with the time of recurrence, and the risk ratios were 0.424, 1.100, 1.084 and 1.268, respectively. Therefore, in male patients with a larger maximum tumor diameter, positivity for Ki-67 and a higher T2 signal ratio, desmoid-type fibromatosis was more likely to recur after surgery.
引用
收藏
页码:869 / 875
页数:7
相关论文
共 50 条
  • [21] Prognostic factors in desmoid-type fibromatosis: a clinicopathological and immunohistochemical analysis of 46 cases
    Huang, Pei-Wen
    Tzen, Chi-Yuan
    PATHOLOGY, 2010, 42 (02) : 147 - 150
  • [23] Desmoid-type fibromatosis-associated Gardner fibromas: prevalence and impact on local recurrence
    Cates, Justin M. M.
    Stricker, Thomas P.
    Sturgeon, Duveen
    Coffin, Cheryl M.
    CANCER LETTERS, 2014, 353 (02) : 176 - 181
  • [24] MRI characteristics predict the efficacy of meloxicam treatment in patients with desmoid-type fibromatosis
    Shimizu, Koki
    Hamada, Shunsuke
    Sakai, Tomohisa
    Ito, Shinji
    Urakawa, Hiroshi
    Arai, Eisuke
    Ikuta, Kunihiro
    Koike, Hiroshi
    Ishiguro, Naoki
    Nishida, Yoshihiro
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2019, 63 (06) : 751 - 757
  • [25] Diagnostic imaging and CEUS findings in a rare case of Desmoid-type fibromatosis. A case report
    Valentino M.
    Liberatore M.
    Maghella F.
    De Soccio V.
    De Felice C.
    Messineo D.
    Drudi F.M.
    Journal of Ultrasound, 2018, 21 (3) : 253 - 257
  • [26] Risk factors of local recurrence after surgery in extraabdominal desmoid-type fibromatosis: A multicenter study in Japan
    Nishida, Yoshihiro
    Hamada, Shunsuke
    Kawai, Akira
    Kunisada, Toshiyuki
    Ogose, Akira
    Matsumoto, Yoshihiro
    Ae, Keisuke
    Toguchida, Junya
    Ozaki, Toshifumi
    Hirakawa, Akihiro
    Motoi, Toru
    Sakai, Tomohisa
    Kobayashi, Eisuke
    Gokita, Tabu
    Okamoto, Takeshi
    Matsunobu, Tomoya
    Shimizu, Koki
    Koike, Hiroshi
    CANCER SCIENCE, 2020, 111 (08) : 2935 - 2942
  • [27] Oral vinorelbine in young patients with desmoid-type fibromatosis
    Kornreich, Laure
    Orbach, Daniel
    Nicolas, Nayla
    Brisse, Herve J.
    Berlanga, Pablo
    Defachelles, Anne-Sophie
    Mansuy, Ludovic
    Verite, Cecile
    Saumet, Laure
    Karanian, Marie
    Corradini, Nadege
    TUMORI JOURNAL, 2023, 109 (05): : 511 - 518
  • [28] Desmoid-type fibromatosis of the breast: A report of 2 cases
    Benej, Roman
    Meciarova, Iveta
    Pohlodek, Kamil
    ONCOLOGY LETTERS, 2017, 14 (02) : 1433 - 1438
  • [29] Efficacy and tolerability of sorafenib in desmoid-type fibromatosis: A need to review dose
    Garg, Vikas
    Gangadharaiah, Bharath B.
    Rastogi, Sameer
    Upadhyay, Ashish
    Barwad, Adarsh
    Dhamija, Ekta
    Gamangatti, Shivanand
    EUROPEAN JOURNAL OF CANCER, 2023, 186 : 142 - 150
  • [30] Desmoid-Type Fibromatosis Evolving Treatment Standards
    Fiore, Marco
    MacNeill, Andrea
    Gronchi, Alessandro
    Colombo, Chiara
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2016, 25 (04) : 803 - +